• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯海拉明:老年女性的药代动力学及精神运动效应

Diphenhydramine: kinetics and psychomotor effects in elderly women.

作者信息

Berlinger W G, Goldberg M J, Spector R, Chiang C K, Ghoneim M

出版信息

Clin Pharmacol Ther. 1982 Sep;32(3):387-91. doi: 10.1038/clpt.1982.176.

DOI:10.1038/clpt.1982.176
PMID:7049503
Abstract

Kinetics and sedative and psychomotor effects of diphenhydramine were investigated in elderly Caucasian women (greater than 64 yr. old). In a double-blind trial, each of 12 healthy subjects received on one of three occasions 50 mg/70 kg IV or oral diphenhydramine HCl or oral placebo. Plasma levels of diphenhydramine were measured in six subjects and tests of sedation and psychomotor performance were performed hourly for 8 hr in all subjects. Kinetic analysis showed that the volume of distribution (295 +/- 50 [SEM] l/70 kg), clearance (42 +/- 5 l/70 kg/hr), and plasma t1/2 (4.9 +/- 0.7 hr) were of the same order as in young adults. As in young adults, there was minimal psychomotor impairment after oral and after intravenous diphenhydramine. In contrast to young adults, however, elderly women did not report significant sedation after diphenhydramine. These results suggest that diphenhydramine may not be an effective sedative/hypnotic in elderly women.

摘要

在老年白人女性(年龄大于64岁)中研究了苯海拉明的动力学以及镇静和精神运动效应。在一项双盲试验中,12名健康受试者中的每一位在三个不同场合分别接受了50mg/70kg静脉注射或口服盐酸苯海拉明或口服安慰剂。对6名受试者测定了苯海拉明的血浆水平,并对所有受试者每小时进行一次长达8小时的镇静和精神运动表现测试。动力学分析表明,分布容积(295±50[标准误]l/70kg)、清除率(42±5l/70kg/小时)和血浆半衰期(4.9±0.7小时)与年轻人处于同一水平。与年轻人一样,口服和静脉注射苯海拉明后精神运动功能受损最小。然而,与年轻人不同的是,老年女性在服用苯海拉明后并未报告有明显的镇静作用。这些结果表明,苯海拉明在老年女性中可能不是一种有效的镇静/催眠药。

相似文献

1
Diphenhydramine: kinetics and psychomotor effects in elderly women.苯海拉明:老年女性的药代动力学及精神运动效应
Clin Pharmacol Ther. 1982 Sep;32(3):387-91. doi: 10.1038/clpt.1982.176.
2
Diphenhydramine in Orientals and Caucasians.东方人和高加索人中的苯海拉明。
Clin Pharmacol Ther. 1980 Aug;28(2):229-34. doi: 10.1038/clpt.1980.155.
3
Correlation between plasma diphenhydramine level and sedative and antihistamine effects.血浆苯海拉明水平与镇静及抗组胺作用之间的相关性。
Clin Pharmacol Ther. 1978 Apr;23(4):375-82. doi: 10.1002/cpt1978234375.
4
Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects.替马西泮、苯海拉明和缬草对健康老年人的急性药理作用。
J Clin Psychopharmacol. 2003 Jun;23(3):260-8. doi: 10.1097/01.jcp.0000084033.22282.b6.
5
Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers.25毫克苯海拉明在青年和老年志愿者体内的药代动力学和药效学
J Clin Pharmacol. 1998 Jul;38(7):603-9. doi: 10.1002/j.1552-4604.1998.tb04466.x.
6
Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.苯海拉明和氯雷他定对镇静、认知、情绪及精神运动表现的初始和稳态效应。
Arch Intern Med. 1997 Nov 10;157(20):2350-6.
7
Characterizing impaired functional alertness from diphenhydramine in the elderly with performance and neurophysiologic measures.通过行为表现和神经生理学测量来表征老年人服用苯海拉明后功能警觉性受损的情况。
Sleep. 2006 Jul;29(7):957-66. doi: 10.1093/sleep/29.7.957.
8
Sedation and memory: studies with a histamine H-1 receptor antagonist.镇静与记忆:组胺H-1受体拮抗剂的研究
J Psychopharmacol. 2006 Jul;20(4):506-17. doi: 10.1177/0269881106059804. Epub 2006 Jan 9.
9
Tolerance to daytime sedative effects of H1 antihistamines.对H1抗组胺药日间镇静作用的耐受性。
J Clin Psychopharmacol. 2002 Oct;22(5):511-5. doi: 10.1097/00004714-200210000-00012.
10
Lack of sedative and cognitive effects of diphenhydramine and cyclobenzaprine in elderly volunteers.苯海拉明和环苯扎林对老年志愿者无镇静和认知作用。
J Psychopharmacol. 1997;11(4):325-9. doi: 10.1177/026988119701100407.

引用本文的文献

1
The Role of Cetirizine in the Changing Landscape of IV Antihistamines: A Narrative Review.西替利嗪在静脉注射抗组胺药不断变化的格局中的作用:叙述性综述。
Adv Ther. 2022 Jan;39(1):178-192. doi: 10.1007/s12325-021-01999-x. Epub 2021 Dec 4.
2
A pharmacokinetic evaluation of five H(1) antagonists after an oral and intravenous microdose to human subjects.对人体受试者口服和静脉注射微量剂量后五种H(1)拮抗剂的药代动力学评估。
Br J Clin Pharmacol. 2009 Mar;67(3):288-98. doi: 10.1111/j.1365-2125.2008.03351.x.
3
Identification of populations at risk in drug testing and therapy: application to elderly patients.
Eur J Drug Metab Pharmacokinet. 1993 Jan-Mar;18(1):101-11. doi: 10.1007/BF03220013.
4
Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).H1受体拮抗剂(抗组胺药)的临床药代动力学
Clin Pharmacokinet. 1985 Nov-Dec;10(6):477-97. doi: 10.2165/00003088-198510060-00002.
5
Hepatic drug metabolism and aging.肝脏药物代谢与衰老
Clin Pharmacokinet. 1990 Nov;19(5):359-89. doi: 10.2165/00003088-199019050-00002.